- 类型
- 身份
- 器官
-
类型/疾病
- FDA999( 32种正常类型组织)
- 乳腺癌
- 促结缔组织增生性小圆细胞肿瘤
- 内分泌肿瘤
- 前列腺癌
- 卵巢癌
- 外阴肿瘤
- 头颈部肿瘤
- 子宫内膜癌
- 宫颈癌
- 寄生虫
- 小细胞肺癌
- 小肠癌
- 平滑肌肉瘤
- 心脏肿瘤
- 恒河猴
- 恶性淋巴瘤
- 恶性黑色素瘤
- 恶性黑色素瘤
- 横纹肌肉瘤
- 淋巴瘤
- 甲状腺癌
- 皮肤癌
- 直肠癌
- 睾丸肿瘤
- 神经肿瘤
- 纤维肉瘤
- 结直肠癌
- 结肠癌
- 肝癌
- 肺腺癌
- 肺鳞状细胞癌
- 肾上腺肿瘤
- 肾嫌色细胞癌
- 肾细胞癌
- 胃癌
- 胃贲门癌
- 胆囊癌
- 胚胎性肿瘤
- 胚胎性肿瘤
- 胰腺癌
- 胸腺瘤
- 脂肪肉瘤
- 脑肿瘤
- 脾脏肿瘤
- 腺癌
- 膀胱癌
- 转移癌
- 软骨肉瘤
- 输卵管癌
- 间皮瘤
- 阑尾肿瘤
- 阴茎肿瘤
- 非小细胞肺癌
- 食管癌
- 食蟹猴
- 骨肉瘤
- 骨髓肿瘤
- 鼻咽癌
- 核心
- 病例
-
点数:10例数:10点样直径（mm）:2厚度（µm）:5行数:3列数:4组织阵列类型:FFPE种属:Human
FMG010
加入收藏
描述: Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores
详情: Breast invasive carcinoma of no special type tissue microarray, containing 10 cases of breast invasive carcinoma of no special type, single cores per case
应用程序: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page
备注
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."
-
说明书列表
-
重复病例
-
下载说明书
图表:
*-Blank-Breast
-
*(*)
-
Malignant(IA)
-
Malignant(IIA)
-
Malignant(IIB)
-
Malignant(IIIB)
组织芯片
FMG010
FMG010
|
1
|
2
|
3
|
4
|
|
|
A
|
{"id":144572,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"A1","cs_0":"1","cs_1":"*","cs_2":"*","cs_3":"*","cs_4":"_pheochromocytoma_ (tissue marker)","cs_5":"*","cs_6":"*","cs_7":"*","cs_8":"*","cs_9":"*","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"*","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"*","cs_21":"*","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
*
|
{"id":144573,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"A2","cs_0":"2","cs_1":"*","cs_2":"*","cs_3":"Blank","cs_4":"Blank","cs_5":"Blank","cs_6":"*","cs_7":"*","cs_8":"*","cs_9":"*","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"*","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"*","cs_21":"*","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null} |
{"id":144574,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"A3","cs_0":"3","cs_1":"35","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"1","cs_6":"T4N2M0","cs_7":"IIIB","cs_8":"Fmg040001","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"++","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144575,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"A4","cs_0":"4","cs_1":"71","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"1","cs_6":"T2N0M0","cs_7":"IIA","cs_8":"Fmg050287","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"+","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
|
B
|
{"id":144576,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"B1","cs_0":"5","cs_1":"56","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T2N1M0","cs_7":"IIB","cs_8":"Fmg010320","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"++","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144577,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"B2","cs_0":"6","cs_1":"47","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T3N0M0","cs_7":"IIB","cs_8":"Fmg040629","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"++","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144578,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"B3","cs_0":"7","cs_1":"33","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T1N0M0","cs_7":"IA","cs_8":"Fmg040118","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"-","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144579,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"B4","cs_0":"8","cs_1":"56","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T2N0M0","cs_7":"IIA","cs_8":"Fmg050234","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"-","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
|
C
|
{"id":144580,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"C1","cs_0":"9","cs_1":"63","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T2N0M0","cs_7":"IIA","cs_8":"Fmg041123","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"+++","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144581,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"C2","cs_0":"10","cs_1":"58","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T2N0M0","cs_7":"IIA","cs_8":"Fmg040130","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"-","cs_21":"3+","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144582,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"C3","cs_0":"11","cs_1":"53","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type (sparse)","cs_5":"*","cs_6":"T2N0M0","cs_7":"IIA","cs_8":"Fmg040131","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"-","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"-","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
{"id":144583,"pid":1890,"update_time":"2025-06-26 16:24:15","create_time":"2025-06-26 16:24:15","pos":"C4","cs_0":"12","cs_1":"46","cs_2":"F","cs_3":"Breast","cs_4":"Invasive carcinoma of no special type","cs_5":"2","cs_6":"T2N0M0","cs_7":"IIA","cs_8":"Fmg040132","cs_9":"Malignant","cs_10":"","cs_11":"","cs_12":"","cs_13":"","cs_14":"","cs_15":"\u00b1(<10%)","cs_16":"","cs_17":"","cs_18":"","cs_19":"","cs_20":"-","cs_21":"-","cs_22":"","cs_23":"","cs_24":"","cs_25":"","cs_26":"","cs_27":"","cs_28":"","cs_29":"","cs_30":"","cs_31":"","cs_32":"","cs_33":"","cs_34":"","cs_35":"","cs_36":"","cs_37":"","cs_38":"","cs_39":"","cs_40":"","cs_41":"","cs_42":"","cs_43":"","cs_44":"","cs_45":null,"new_cs":null}
Bre
|
FMG010
-
年龄:
-
性别:
-
器官/解剖部位:
-
病理诊断:
-
等级:
-
分期:
-
阶段:
-
类型:
| 位置 | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | Grade | TNM | Stage | Type | Ki-67 | PR | Her-2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
A1
|
1 | * | * | * | _pheochromocytoma_ (tissue marker) | * | * | * | * | * | * | * |
|
A2
|
2 | * | * | Blank | Blank | Blank | * | * | * | * | * | * |
|
A3
|
3 | 35 | F | Breast | Invasive carcinoma of no special type | 1 | T4N2M0 | IIIB | Malignant | - | ++ | - |
|
A4
|
4 | 71 | F | Breast | Invasive carcinoma of no special type | 1 | T2N0M0 | IIA | Malignant | - | + | - |
|
B1
|
5 | 56 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant | - | ++ | - |
|
B2
|
6 | 47 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant | - | ++ | - |
|
B3
|
7 | 33 | F | Breast | Invasive carcinoma of no special type | 2 | T1N0M0 | IA | Malignant | - | - | - |
|
B4
|
8 | 56 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant | - | - | - |
|
C1
|
9 | 63 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant | - | +++ | - |
|
C2
|
10 | 58 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant | - | - | 3+ |
|
C3
|
11 | 53 | F | Breast | Invasive carcinoma of no special type (sparse) | * | T2N0M0 | IIA | Malignant | - | - | - |
|
C4
|
12 | 46 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant | ±(<10%) | - | - |
如需了解产品规格方面的任何问题，请联系我们：support@arraysbank.com
